Patient Retention in Orphan Drug Studies June 7, 2007, Presented by Xtalks and Clinical Resource Network

Share Article

Patient recruitment is a significant and often complicated element of clinical trial process. Join Lisa A. Ward, MPH Clinical Research Manager from Genzyme Corporation who is sharing her case-study on "A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study". Patient retention in Orphan Drug Studies Webinar June 8, 2007

Xtalks and Clinical Resource Network are pleased to present the web conference Patient Retention in Orphan Drug Studies, scheduled for June 7, 2007, featuring presentations by Lisa A. Ward, MPH Clinical Research Manager, Genzyme Corporation and Gail Adinamis, President, CEO, Clinical Resource Network, Inc.

Patient recruitment is a significant and often complicated element of clinical trial process. Challenges that companies may experience include timing of product approval and adaptive design implementation as well as regional differences and participant expectations.

Join Lisa A. Ward, MPH Clinical Research Manager from Genzyme Corporation who is sharing her case-study on "A Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of Myozyme, Recombinant Human Acid Alpha-Glucosidase (rhGAA), Treatment in Patients with Late-Onset Pompe Disease."

Take away points:

  •     Site selection and recruitment strategies
  •     Importance of patient advocacy support
  •     Regional differences and participant expectations
  •     Acknowledge and address barriers to participation & moral concerns
  •     Retention strategies

The Patient Retention in Orphan Drug Studies web conference takes place June 8, 2007, from 11:00 a.m. - 1:00 p.m. EDT.

Register at: http://www.xtalks.com/patientretention.ashx            

About the Clinical Resource Network, Inc.:
Clinical Resource Network, Inc. is a leading national provider of specialized in-home and alternate-site nursing, pharmacy and phlebotomy services for phase I-IV studies conducted in the US and Canada. These services decrease development time by accelerating patient enrollment, enhancing compliance and reducing dropouts. CRN supports trials in all therapeutic categories and age groups. CRN centrally manages an extensive network of over 10,000 traveling nurses and homecare pharmacists and over 5,000 mobile phlebotomists. http://www.clinicalresource.net/

About Xtalks
Xtalks is part of The Honeycomb Worldwide Group of Companies. Honeycomb Worldwide creates peer-to-peer business-oriented social networking communities, connecting senior level executives by delivering content through new and established media channels and is currently ranked 15th on the Profit Hot 50 List of emerging Canadian companies. http://www.honeycombworldwide.com.

For more information on this conference or Xtalks in general, or to enquire about speaking opportunities or sponsoring future events, visit http://www.xtalks.com or contact Karen Anderson, Chief Marketing Officer, at phone: 312-977-1166, x. 1209.

Register at http://www.xtalks.com/patientretention.ashx

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

KAREN ANDERSON
Xtalks
312-977-1166
Email >
Visit website